Seven Eight Capital LP Makes New $397,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Seven Eight Capital LP purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,237 shares of the company’s stock, valued at approximately $397,000.

Other large investors have also bought and sold shares of the company. MFA Wealth Advisors LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC acquired a new stake in HCA Healthcare in the second quarter worth $28,000. Bangor Savings Bank grew its stake in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the period. GPS Wealth Strategies Group LLC boosted its holdings in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $33,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Up 0.3 %

Shares of NYSE HCA opened at $404.66 on Monday. The business’s fifty day moving average price is $370.57 and its 200-day moving average price is $340.70. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $405.70. The stock has a market capitalization of $105.99 billion, a PE ratio of 20.17, a P/E/G ratio of 1.46 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. During the same quarter in the previous year, the firm posted $4.29 earnings per share. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent research reports. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Monday, August 19th. UBS Group raised their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Deutsche Bank Aktiengesellschaft increased their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Finally, Leerink Partners increased their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Activity

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock worth $6,407,273 in the last three months. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.